Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
Clinical trial NCT05461690 · UNKNOWN
Trial details
- NCT number
- NCT05461690
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.